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Key Clinical Message
In addition to detecting trisomies of whole chromosomes, QF-PCR can also
detect partial trisomies of the chromosomes 13, 18, and 21, which can suggest
an unbalanced translocation. Additional testing with other techniques, such as
microarray or FISH, is recommended when an unbalanced translocation is sus-
pected.
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What does this study add?
• QF-PCR can also detect partial trisomies of the chro-
mosomes 13, 18, and 21, which can suggest an unbal-
anced translocation.
• Additional testing with other techniques, such as
microarray or FISH, is recommended when an unbal-
anced translocation is suspected.
Aneuploidy of the sex chromosomes and of chromosomes
13, 18, and 21 can be detected by quantitative fluores-
cence polymerase chain reaction (QF-PCR) performed
with STR markers for chromosomes X, Y, 13, 18, and 21.
Although QF-PCR is designed for the detection of whole-
chromosome trisomies, partial trisomies of the investi-
gated chromosomes may be detected. A trisomy pattern
of one STR marker may either point to a partial trisomy
with serious clinical consequences or may indicate a poly-
morphic variant, a submicroscopic polymorphic duplica-
tion of microsatellites of this specific marker as is found
in some healthy individuals [1].
Here, we report a case of a healthy 36-year-old female
patient, gravidity 2 parity 0, who visited the Department
of Maternal Fetal Medicine in our hospital. Her family
history was noncontributory, and the patient and her
partner were not consanguineous. In her first pregnancy
at the age of 35 years, a first-trimester screening for
Down syndrome revealed an increased risk of trisomy 21
when an increased nuchal translucency (NT) of 13 mm
was detected. A chorionic villus biopsy was performed,
and conventional karyotyping indeed showed trisomy 21.
The fetus had a nonhereditary form of Down syndrome.
The patient and her partner decided to terminate the
pregnancy. In her second pregnancy at the age of
37 years, the patient opted for first-trimester screening.
The NT was normal (1.3 mm); however, the pregnancy-
associated plasma protein A (PAPP-A) and free beta-
human chorionic gonadotropin (bHCG) were 371 mU/L
and 157 lg/L, respectively, indicating an increased risk of
a child with Down syndrome. Amniocentesis was per-
formed at 14 weeks and 5 days of gestation, and QF-PCR
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(Aneufast kit, version 2; Genomed Diagnostics AG,
Switzerland) showed a triallelic trisomy pattern only for
the STR marker D21S1411 (21q22.3) of chromosome 21.
A minimum of two informative markers is required to
confirm an abnormal result. Because only one of five
markers was informative, additional markers were used.
One other STR marker, D21S1412 (21q22.2), also showed
a triallelic pattern (Fig. 1A and B). The two informative
STR markers are located in adjacent sub-bands on chro-
mosome 21q22. Therefore, a partial trisomy of chromo-
some 21 could not be excluded. Chromosomes 13 and 18
showed a normal pattern. The patient was referred to the
Department of Clinical Genetics for counseling and addi-
tional testing. QF-PCR performed on DNA of the patient
and her partner did not show the duplication of the STR
markers concerned, and it revealed that the extra alleles
of markers D21S1412 and D21S1411 in the fetus origi-
nated from the patient’s partner. As QF-PCR is the first
tier test in our center, conventional karyotyping was sub-
sequently performed, which initially showed a normal
male chromosomal pattern in the fetus. Additional tar-
geted 180K array CGH (Agilent Technologies, Santa
Clara, USA; Amadid 023363) showed a duplication of
approximately 4.98 Mb of parts of chromosome bands
21q22.2 and q22.3 (ISCN: arr[hg18] 21q22.2q22.3
(39,119,758-44,102,267)x3) (Fig. 1C). In this particular
region of chromosome 21, many RefSeq genes are located,
which may be of consequence for the phenotype of the
fetus. BRWD1 is located within the Down syndrome
region-2, WRB has a potential role in the pathogenesis of
Down syndrome congenital heart disease, WDR4 could
be a candidate for the development of Down syndrome
phenotypes, and DSCAM is linked to cardiac defects and
contributes to defects in the central nervous system of
patients with Down syndrome [2–7].
FISH testing, performed after the microarray, on cells
of the fetus with probes that hybridize to chromosome
band 21q22.3 showed a signal on both chromosome 21
and a third signal on chromosome 16. Conventional kary-
otyping and FISH on cells from the patient’s partner
showed a balanced interchromosomal insertion: 46,XY.ish
ins(16;21)(q22;q22.2q22.3)(RP11-566C12+,RP11-891L10+,
RP11-619I15+;RP11-566C12-,RP11-891L10-,RP11-619I15-
) (Fig. 1E). The resulting karyotype of the fetus was 46,
XY.ish der(16)ins(16;21)(q22;q22.2q22.3)(RP11-566C12+,
RP11-891L10+,RP11-619I15+)pat, showing a submicro-
scopic insertion of chromosome band 21q22.2q22.3 in the
long arm of chromosome 16 (Fig. 1D). The couple was
counseled about the high risk of a Down syndrome phe-
notype and subsequently chose to terminate the preg-
nancy before 20 weeks of gestation. No ultrasound
findings were seen during pregnancy. A viewing of the
fetus after birth showed some mild dysmorphic features
seen in Down syndrome (upslant of the eyes, telecanthus,
low-set ears, increased nuchal fold, possibly a mild sandal
gap). No autopsy was performed. The recurrence risk of
an unbalanced insertion translocation in a next pregnancy
theoretically is 50%. The couple opted for preimplanta-
tion genetic diagnosis (PGD) for future pregnancies, and
the patient got pregnant after the first cycle. However, a
miscarriage occurred. In the next PGD attempt, the
patient became pregnant again and a healthy baby boy
was born.
In the literature, several reports about 21q duplications
have been published and most published partial duplica-
tions on 21q show a Down phenotype in the fetus or
child. Reports that resemble our duplication the most are
published by Qi et al. [8] and Lee et al. [9]. However,
Qi’s case shows a larger duplication at the same region
with concomitant deletion and other duplications of small
fragments in 21q and Lee et al. published a case with a
duplication of chromosome region 21q22.13q22.2, which
is more proximal than in our case. Additionally, in Lee’s
case microarray was not performed. Recently, a report
was published in which a partial 21q duplication did not
show an obvious abnormal phenotype. The duplicated
region resembled our case [10]. It is difficult to say what
the exact phenotype in our case would have been as the
pregnancy was terminated. However, based on the litera-
ture at the time our case presented, we counseled a high
risk of a Down phenotype in our fetus.
For the sake of completeness, the fetus from the
patient’s first pregnancy was investigated with FISH with
the same probes specific for the duplicated region of
chromosome 21. This fetus had a trisomy 21 due to
nondisjunction, and it had the same balanced insertion
translocation ins(16;21) as the patient’s partner. There
was no material left from the first fetus, and therefore, it
was impossible to determine whether the trisomy 21
observed in the first fetus was due to a nondisjunction in
the patient or her partner. An association between the
two pregnancies seems attractive in theory, but an inter-
chromosomal effect cannot be proven. A mechanism that
would explain both abnormal pregnancies is unlikely on
the basis of meiotic figures that are theoretically formed
in the balanced carrier of the interchromosomal insertion.
Our case illustrates the utilization of QF-PCR in prenatal
samples to detect not only common trisomies, but also
potential segmental trisomies and to precisely delineate
the abnormality in conjunction with other techniques
such as conventional karyotyping, FISH, and microarray.
Additionally, our case shows the importance of parental
testing to provide appropriate genetic counseling for
managing future pregnancies.
1314 ª 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Prenatal partial T21 due to ins(16;21) S. L. Bhola et al.
Figure 1. (A) QF-PCR of fetus showing triallelic trisomy pattern for the STR marker D21S1411 (21q22.3) (red box); (B) additional STR marker,
D21S1412 (21q22.2), showing triallelic trisomy pattern; (C) 180K microarray showing a duplication approximately 4.98 Mb of parts of chromosome
bands 21q22.2 and q22.3; (D) FISH on fetal material showing a submicroscopic insertion of chromosome band 21q22.2q22.3 in the long arm of
chromosome 16; and (E) FISH on the patient’s partner showing a balanced interchromosomal insertion: 46,XY.ish ins(16;21)(q22;q22.2q22.3).
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